U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07084961) titled 'A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects' on July 17.
Brief Summary: An open-label, single-center, crossover study to evaluate the impact of administration timing of TS-172 on the pharmacodynamics in healthy adult male subjects.
Study Start Date: Aug. 05
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Male Subjects
Intervention:
DRUG: TS-172
Oral administration of TS-172 20 mg immediately before meal
DRUG: TS-172
Oral administration of TS-172 20 mg immediately after meal
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Taisho Pharmaceutical Co., Ltd.
Published by HT Digital Content Services wit...